MoAb HuM195
Jump to navigation
Jump to search
MoAb HuM195 | |
---|---|
Term | MoAb HuM195 |
Short definition | MoAb HuM195 - A substance being studied for the treatment of myelodysplastic syndromes and some types of leukemia. It attaches to CD33, a protein on the surface of certain normal blood stem cells and some abnormal blood cells. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
MoAb HuM195 - A substance being studied for the treatment of myelodysplastic syndromes and some types of leukemia. It attaches to CD33, a protein on the surface of certain normal blood stem cells and some abnormal blood cells. It causes the immune system to kill these cells. MoAb HuM195 is a type of monoclonal antibody. Also called lintuzumab and monoclonal antibody HuM195
External links
- Medical encyclopedia article on MoAb HuM195
- Wikipedia's article - MoAb HuM195
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski